12:27 PM
 | 
Jul 12, 2018
 |  BC Extra  |  Financial News

Haitong leads Orig3n's series B

Regenerative medicine company Orig3n Inc. (Boston, Mass.) said it had an initial close of a series B round led by Haitong International. Orig3n did not disclose how much it raised in the initial close; however, it...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >